We are live on ! Find out more
KA

Kozak & Associates Portfolio holdings

AUM $576M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+23.37%
3 Year Est. Return
+97.43%
5 Year Est. Return
+117.62%
10 Year Est. Return
–
AUM
$248M
AUM Growth
+$25.2M
Cap. Flow
-$355K
Cap. Flow %
-0.14%
Top 10 Hldgs %
76.44%
Holding
367
New
28
Increased
133
Reduced
23
Closed
10

Top Buys

Rank Stock Value
1
IETC icon
iShares US Tech Independence Focused ETF
IETC
+$348K
2
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$337K
3
IYG icon
iShares US Financial Services ETF
IYG
+$239K
4
AAPL icon
Apple
AAPL
+$207K
5
DE icon
Deere & Co
DE
+$195K

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$605K
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$421K
3
IDXX icon
Idexx Laboratories
IDXX
+$400K
4
A icon
Agilent Technologies
A
+$319K
5
BIDU icon
Baidu
BIDU
+$178K

Sector Composition

Rank Sector Weight
1 Technology 15.19%
2 Consumer Discretionary 4.63%
3 Financials 4.62%
4 Consumer Staples 2.47%
5 Industrials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD icon
326
DuPont de Nemours
DD
$19.3B
$1.16K ﹤0.01%
13
– –
TDOC icon
327
Teladoc Health
TDOC
$1.22B
$1.15K ﹤0.01%
45
– –
BPT
328
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$1.15K ﹤0.01%
+250
New +$1.5K
LUMN icon
329
Lumen
LUMN
$6.91B
$1.12K ﹤0.01%
499
– –
TSN icon
330
Tyson Foods
TSN
$20.7B
$1.11K ﹤0.01%
21
– –
NYC
331
American Strategic Investment Co
NYC
$29.7M
$1.11K ﹤0.01%
154
– –
VOOV icon
332
Vanguard S&P 500 Value ETF
VOOV
$6.7B
$1.09K ﹤0.01%
+7
New +$1.04K
MUFG icon
333
Mitsubishi UFJ Financial
MUFG
$246B
$971 ﹤0.01%
130
– –
CTVA icon
334
Corteva
CTVA
$52.2B
$919 ﹤0.01%
16
– –
UVXY icon
335
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$245M
$918 ﹤0.01%
2
– –
CI icon
336
Cigna
CI
$72.4B
$878 ﹤0.01%
3
– –
VNQ icon
337
Vanguard Real Estate ETF
VNQ
$39.2B
$759 ﹤0.01%
+9
New +$737
NVTA
338
DELISTED
Invitae Corporation
NVTA
$755 ﹤0.01%
645
– –
VVOS icon
339
Vivos Therapeutics
VVOS
$6.42M
$602 ﹤0.01%
48
– –
SNAP icon
340
Snap
SNAP
$9.74B
$601 ﹤0.01%
50
– –
WRAP icon
341
Wrap Technologies
WRAP
$110M
$573 ﹤0.01%
399
– –
CIVI
342
DELISTED
Civitas Resources
CIVI
$492 ﹤0.01%
7
– –
VTRS icon
343
Viatris
VTRS
$20.6B
$454 ﹤0.01%
46
-1
-2% -$10
TSP
344
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$333 ﹤0.01%
181
– –
ENFY
345
DELISTED
Enlightify Inc
ENFY
$324 ﹤0.01%
121
– –
VIOV icon
346
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.91B
$248 ﹤0.01%
+3
New +$237
OXY.WS icon
347
Occidental Petroleum Corp Warrants
OXY.WS
$31B
$223 ﹤0.01%
6
– –
BLDP
348
Ballard Power Systems
BLDP
$826M
$109 ﹤0.01%
+25
New +$114
GRMN
349
Garmin
GRMN
$59.3B
$102 ﹤0.01%
1
– –
ESGD icon
350
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.2B
$73 ﹤0.01%
+1
New +$73
11 12 13
14
15

Similar funds

SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
EIP
Ellis Investment Partners Berwyn, Pennsylvania $576M AUM 16.04% 1-Year Est. Return
GAM
Gould Asset Management Claremont, California $576M AUM 12.34% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
PG
Patten Group Chattanooga, Tennessee $575M AUM 21.99% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
IDA
Intelligence Driven Advisers Carlsbad, California $574M AUM 16.47% 1-Year Est. Return

Kozak & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Kozak & Associates held 367 positions worth $248M, up 11% from $223M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Kozak & Associates's Q2 2023 filing shows 28 new, 133 increased, 23 reduced and 10 closed positions. Its largest new stake was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K. The largest sale was Thermo Fisher Scientific, an estimated $605K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Kozak & Associates's largest Q2 2023 buy was iShares Core Universal USD Bond ETF: 536 shares worth $24.2K.
  • Kozak & Associates added most to iShares US Tech Independence Focused ETF in Q2 2023, an estimated $348K increase.
  • Kozak & Associates's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $421K.
  • Kozak & Associates fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $605K.
  • Kozak & Associates's ten largest holdings make up 76% of its $248M portfolio in Q2 2023.
  • Kozak & Associates opened 28 new positions and closed 10 in Q2 2023.
  • Kozak & Associates's portfolio value rose 11% quarter-over-quarter to $248M.

Based on Kozak & Associates's 13F filing for Q2 2023, filed 5 Jul 2023.